ARTV vs UNH · $37.3M cap vs P/E 30, rev $112.03B
Artiva Biotherapeutics, Inc. Common Stock (ARTV) versus UnitedHealth Group Incorporated (UNH) — a side-by-side from cached financials, not a winner call.
Artiva Biotherapeutics, Inc. Common Stock (ARTV) is a biotechnology company listed on US.
UnitedHealth Group Incorporated (UNH) is a healthcare plans company listed on NYSE. It is led by Stephen J. Hemsley.
Latest reported ARTV revenue for 2025-12-31 was $0. Net income was -$83.9M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. ARTV currently screens at market cap $37.3M.
Latest reported UNH revenue for 2026-06-30 was $112.03B. Net income was $5.48B. Revenue was up 0.3% from 2026-03-31 to 2026-06-30. UNH currently screens at market cap $362.83B and trailing P/E 30.1.
ARTV currently screens at market cap $37.3M. UNH currently screens at market cap $362.83B and trailing P/E 30.1.
Not investment advice. Open the ARTV and UNH stock pages for the full models.
Not investment advice.